Kidney (Renal) Problems & HIV

Three Kidney Metrics Worse With HIV Than Without in Aging Adults (October 16, 2017)
From TheBodyPRO.com
Switching to Genoya Plus Prezista Maintains Viral Suppression, Improves Renal Markers (March 15, 2017)
From TheBodyPRO.com
Hepatitis C Increases Risk of Some Nonliver Diseases in People With HIV (March 7, 2017)
From TheBodyPRO.com
Heart, Kidney, Bone Disease Rates Higher With Than Without HIV Over 2003-2013 (November 17, 2016)
In IDWeek 2016, from TheBodyPRO.com
Kidney and Bone Markers Improve After TDF-to-TAF Switch in People 50 or Older (November 15, 2016)
In IDWeek 2016, from TheBodyPRO.com
Fanconi-Like Lab Abnormalities Reported With Daily PrEP: Importance of Routine Kidney Monitoring (September 14, 2016)
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
Three Non-AIDS Illnesses Tied to Cognitive Impairment in Men With HIV (September 1, 2016)
From TheBodyPRO.com
Slow But Steady Increase in Kidney Risk Observed With TDF, Atazanavir, Lopinavir (August 24, 2016)
From TheBodyPRO.com
For Injection Drug Users With HIV, Higher Risk of Liver/Kidney Disease -- But Not Other Non-AIDS Ills (August 23, 2016)
From TheBodyPRO.com
Kidney Function Better Over 2 Years With Immediate ART in START Trial (August 4, 2016)
In The 21st International AIDS Conference (AIDS 2016), from TheBodyPRO.com
Fewer Renal or Bone Events With Atripla Than Stribild in Large Database (July 28, 2016)
In ASM Microbe 2016, from TheBodyPRO.com
Starting Treatment With First-Line Protease Inhibitors May Increase Kidney Disease Risk (July 8, 2016)
From TheBodyPRO.com
All Systems GO: Three Organ Systems Affected by Aging, Medications and HIV (Summer 2016)
In Positively Aware, from Test Positive Aware Network
Serious Kidney Problems Are Rare With PrEP, but Increase With Older Age and Better Adherence (April 5, 2016)
In The 23rd Conference on Retroviruses and Opportunistic Infections, from Project Inform
On TheBodyPRO.com
How PrEP Changes Kidney Function (March 8, 2016)
In The 23rd Conference on Retroviruses and Opportunistic Infections, from BETA
On TheBodyPRO.com
Kidney Risk Climbs With Increasing Time on Tenofovir, Atazanavir or Lopinavir (February 21, 2016)
From TheBodyPRO.com
Tenofovir Alafenamide (TAF) in People With Kidney Dysfunction (October/November 2015)
In TreatmentUpdate, from Canadian AIDS Treatment Information Exchange
On TheBodyPRO.com
Inflammation Markers Tied to Worse Kidney Function in Men Taking Antiretroviral Therapy (October 20, 2015)
From TheBodyPRO.com
Single-Tablet HIV Regimen Containing Tenofovir Alafenamide Improves Bone and Kidney Safety (September 21, 2015)
In The 55th Interscience Conference on Antimicrobial Agents and Chemotherapy, from TheBodyPRO.com
Tenofovir Alafenamide (TAF) Gentler on the Bones and Kidneys (April 3, 2015)
In The 22nd Conference on Retroviruses and Opportunistic Infections (CROI 2015), from TheBodyPRO.com
Long-Term Tenofovir Use Associated With Higher Rates of Kidney Problems (November 14, 2014)
In IDWeek 2014, from TheBodyPRO.com

1 | 2 | 3 | 4 | 5 Next >

More Most Viewed Articles

HIV Tools You Can Use

Track Your CD4 Count, Viral Load and More: Use TheBody.com's Health Tracker

TheBody.com's App
TheBody.com's Medication and Health Reminders
TheBody.com's Facebook, RSS Feeds and Twitter
Are You at Risk for HIV? Take Our Quiz!
U.S. ASO Listings
International ASOs

The Body is a service of Remedy Health Media, LLC, 750 3rd Avenue, 6th Floor, New York, NY 10017. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.